ASCO Guidelines Bundle

Save over 20% by purchasing the entire ASCO Guidelines Bundle!

The following GUIDELINES Pocket Guides are included in this bundle.  They are developed in collaboration with and are approved by the American Society of Clinical Oncology.

• Adjuvant Therapy for Stage III Colon Cancer
• Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
• Advanced Ovarian Cancer
• Antiemetics
• Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression
• Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer
• Axilla Management
• Bone-Modifying Agents in Early Breast Cancer
• Bone-Modifying Agents in Metastatic Breast Cancer
• Bone-Modifying Agents in Multiple Myeloma
• Breast Cancer Biomarkers
• Breast Cancer Risk Reduction
• Cancer-associated Anemia Erythropoiesis-Stimulating Agents
• Cancer Cachexia
• Cardiac Dysfunction in Cancer
• Chemotherapy-Induced Peripheral Neuropathy
• Chemotherapy-Naive Castration-Resistant Prostate Cancer
• Cervical Cancer Prevention
• Chronic Pain in Cancer
• Colorectal Cancer Biomarkers
• Colorectal Cancer Early Detection
• Dyspnea in Advanced Cancer
• Early Stage Breast Cancer
• Estrogen and Progesterone Receptor Testing in Breast Cancer
• Fertility Preservation
• Fever & Neutropenia
• Geriatric Chemotherapy
• Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
• Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
• HER2 Testing in Breast Cancer
• Hormone Receptor-Positive Breast Cancer Adjuvant Endocrine Therapy
• HR-Positive, HER2-Negative Metastatic Breast Cancer
• Immune-related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
• Invasive Cervical Cancer
• Larynx Preservation
• Late-Stage Colorectal Cancer
• Lung Cancer Surveillance
• Malignant Pleural Mesothelioma
• Management of Hereditary Breast Cancer
• Management of Male Breast Cancer
• Management of p16+ Oropharyngeal Cancer
• Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
• Medication-Related Osteonecrosis of the Jaw
• Metastatic Carcinoma and Myeloma of the Femur
• Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
• Noncastrate Advanced, Recurrent or Metastatic Prostate Cancer Initial Management
• Molecular Biomarkers in Localized Prostate Cancer
• Multiple Myeloma Treatment
• Nasopharyngeal Carcinoma
• Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
• Optimum Imaging Strategies for Advanced Prostate Cancer
• Osteoporosis in Survivors of Adult Cancers
• Pancreatic Cancer Evaluating Susceptibility
• Palliative Care in the Global Setting
• PARP Inhibitors in the Management of Ovarian Cancer
• Platelet Transfusion
• Potentially Curable Pancreatic Adenocarcinoma
• Resected Biliary Tract Cancer
• Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
• Salivary Gland Hypofunction and/or Xerostomia
• Salivary Gland Malignancy
• Small Renal Masses
• Squamous Cell Carcinoma of Unknown Primary
• Stage IV Non-Small Cell Lung Cancer with Driver Alterations
• Stage IV Non-Small-Cell Lung Cancer
• Systemic Therapy for Advanced Hepatocellular Carcinoma
• Systemic Therapy for Melanoma
• Treatment of Early-Stage Colorectal Cancer
• Treatment of Locally Advanced Esophageal Carcinoma
• Venous Thromboembolism in Patients with Cancer
• White Blood Cell Growth Factors

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.